Listed

Tempest Therapeutics, Inc.

TPSTNasdaqCIK 1544227HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$5.3m, Q2 FY2026
Net income−$5.2m, Q2 FY2026
Tempest Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(6.6)Operating income, Q3 FY2023, three months to 2023-09-30−$6.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figure(7.5)Operating income, Q4 FY2023, three months to 2023-12-31−$7.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0000950170-25-046144. Derived: 12-month figure less the 9-month figure.Report this figure(8.0)Operating income, Q1 FY2024, three months to 2024-03-31−$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure(9.6)Operating income, Q2 FY2024, three months to 2024-06-30−$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0000950170-25-106558.Report this figure(10.6)Operating income, Q3 FY2024, three months to 2024-09-30−$10.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure(13.9)Operating income, Q4 FY2024, three months to 2024-12-31−$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-130490. Derived: 12-month figure less the 9-month figure.Report this figure(10.9)Operating income, Q1 FY2025, three months to 2025-03-31−$10.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure(8.0)Operating income, Q2 FY2025, three months to 2025-06-30−$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure(3.6)Operating income, Q3 FY2025, three months to 2025-09-30−$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure(4.1)Operating income, Q4 FY2025, three months to 2025-12-31−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-130490. Derived: 12-month figure less the 9-month figure.Report this figure(27.7)Operating income, Q1 FY2026, three months to 2026-03-31−$27.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure(5.3)Operating income, Q2 FY2026, three months to 2026-06-30−$5.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure
Interest expense$m0.4Interest expense, Q3 FY2023, three months to 2023-09-30$373.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-08, accession 0000950170-23-061278.Report this figure0.4Interest expense, Q4 FY2023, three months to 2023-12-31$377.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-19, accession 0000950170-24-033555. Derived: 12-month figure less the 9-month figure.Report this figure0.4Interest expense, Q1 FY2024, three months to 2024-03-31$368.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0000950170-24-057072.Report this figure0.4Interest expense, Q2 FY2024, three months to 2024-06-30$372.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-08, accession 0000950170-24-094124.Report this figure0.3Interest expense, Q3 FY2024, three months to 2024-09-30$329.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure0.2Interest expense, Q4 FY2024, three months to 2024-12-31$247.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-30, accession 0001193125-26-130490. Derived: 12-month figure less the 9-month figure.Report this figure0.2Interest expense, Q1 FY2025, three months to 2025-03-31$161.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$46.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-30, accession 0001193125-26-130490. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-27, accession 0000950170-25-046144. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-11, accession 0000950170-25-106558.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-30, accession 0001193125-26-130490. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-30, accession 0001193125-26-130490. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure
Net income$m(6.8)Net income, Q3 FY2023, three months to 2023-09-30−$6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figure(7.5)Net income, Q4 FY2023, three months to 2023-12-31−$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0000950170-25-046144. Derived: 12-month figure less the 9-month figure.Report this figure(7.9)Net income, Q1 FY2024, three months to 2024-03-31−$7.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure(9.6)Net income, Q2 FY2024, three months to 2024-06-30−$9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure(10.6)Net income, Q3 FY2024, three months to 2024-09-30−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure(13.8)Net income, Q4 FY2024, three months to 2024-12-31−$13.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-130490. Derived: 12-month figure less the 9-month figure.Report this figure(10.9)Net income, Q1 FY2025, three months to 2025-03-31−$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure(7.9)Net income, Q2 FY2025, three months to 2025-06-30−$7.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure(3.5)Net income, Q3 FY2025, three months to 2025-09-30−$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure(4.0)Net income, Q4 FY2025, three months to 2025-12-31−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-130490. Derived: 12-month figure less the 9-month figure.Report this figure(27.7)Net income, Q1 FY2026, three months to 2026-03-31−$27.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure(5.2)Net income, Q2 FY2026, three months to 2026-06-30−$5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure
Diluted EPS$ per share(0.48)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figurenot reported(4.62)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$4.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure(5.52)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$5.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0000950170-25-106558.Report this figure(5.32)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$5.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figurenot reported(3.16)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$3.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure(2.07)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$2.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure(0.79)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figurenot reported(2.53)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$2.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure(0.34)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure
Basic EPS$ per share(0.48)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figurenot reported(4.62)Basic EPS, Q1 FY2024, three months to 2024-03-31−$4.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure(5.52)Basic EPS, Q2 FY2024, three months to 2024-06-30−$5.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0000950170-25-106558.Report this figure(5.32)Basic EPS, Q3 FY2024, three months to 2024-09-30−$5.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figurenot reported(3.16)Basic EPS, Q1 FY2025, three months to 2025-03-31−$3.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure(2.07)Basic EPS, Q2 FY2025, three months to 2025-06-30−$2.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure(0.79)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.79 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figurenot reported(2.53)Basic EPS, Q1 FY2026, three months to 2026-03-31−$2.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure(0.34)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure

Balance sheet

Cash and equivalents$779.0k, Q2 FY2026
Long-term debt$4.2m, Q1 FY2025
Shareholders' equity−$1.1m, Q2 FY2026
Tempest Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m11.1Cash and equivalents, Q3 FY2023, at 2023-09-30$11.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0000950170-23-061278.Report this figure39.2Cash and equivalents, FY2023, at 2023-12-31$39.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-27, accession 0000950170-25-046144.Report this figure32.3Cash and equivalents, Q1 FY2024, at 2024-03-31$32.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0000950170-24-057072.Report this figure31.1Cash and equivalents, Q2 FY2024, at 2024-06-30$31.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-094124.Report this figure22.1Cash and equivalents, Q3 FY2024, at 2024-09-30$22.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figure30.3Cash and equivalents, FY2024, at 2024-12-31$30.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001193125-26-130490.Report this figure21.5Cash and equivalents, Q1 FY2025, at 2025-03-31$21.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure14.3Cash and equivalents, Q2 FY2025, at 2025-06-30$14.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0000950170-25-106558.Report this figure7.5Cash and equivalents, Q3 FY2025, at 2025-09-30$7.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure7.7Cash and equivalents, FY2025, at 2025-12-31$7.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure1.8Cash and equivalents, Q1 FY2026, at 2026-03-31$1.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure0.8Cash and equivalents, Q2 FY2026, at 2026-06-30$779.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure
Current assets$m12.3Current assets, Q3 FY2023, at 2023-09-30$12.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061278.Report this figure40.4Current assets, FY2023, at 2023-12-31$40.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0000950170-25-046144.Report this figure33.5Current assets, Q1 FY2024, at 2024-03-31$33.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-057072.Report this figure31.5Current assets, Q2 FY2024, at 2024-06-30$31.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094124.Report this figure23.6Current assets, Q3 FY2024, at 2024-09-30$23.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figure31.5Current assets, FY2024, at 2024-12-31$31.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001193125-26-130490.Report this figure22.4Current assets, Q1 FY2025, at 2025-03-31$22.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure15.1Current assets, Q2 FY2025, at 2025-06-30$15.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0000950170-25-106558.Report this figure8.1Current assets, Q3 FY2025, at 2025-09-30$8.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure8.3Current assets, FY2025, at 2025-12-31$8.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure2.4Current assets, Q1 FY2026, at 2026-03-31$2.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure1.7Current assets, Q2 FY2026, at 2026-06-30$1.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure
Total assets$m24.0Total assets, Q3 FY2023, at 2023-09-30$24.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061278.Report this figure51.6Total assets, FY2023, at 2023-12-31$51.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0000950170-25-046144.Report this figure44.4Total assets, Q1 FY2024, at 2024-03-31$44.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-057072.Report this figure42.2Total assets, Q2 FY2024, at 2024-06-30$42.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-094124.Report this figure33.8Total assets, Q3 FY2024, at 2024-09-30$33.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figure41.5Total assets, FY2024, at 2024-12-31$41.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001193125-26-130490.Report this figure32.2Total assets, Q1 FY2025, at 2025-03-31$32.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure24.5Total assets, Q2 FY2025, at 2025-06-30$24.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0000950170-25-106558.Report this figure17.1Total assets, Q3 FY2025, at 2025-09-30$17.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure16.9Total assets, FY2025, at 2025-12-31$16.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure10.7Total assets, Q1 FY2026, at 2026-03-31$10.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure9.6Total assets, Q2 FY2026, at 2026-06-30$9.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure
Current liabilities$m7.4Current liabilities, Q3 FY2023, at 2023-09-30$7.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061278.Report this figure9.4Current liabilities, FY2023, at 2023-12-31$9.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0000950170-25-046144.Report this figure10.7Current liabilities, Q1 FY2024, at 2024-03-31$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-057072.Report this figure14.6Current liabilities, Q2 FY2024, at 2024-06-30$14.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094124.Report this figure14.0Current liabilities, Q3 FY2024, at 2024-09-30$14.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figure14.2Current liabilities, FY2024, at 2024-12-31$14.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001193125-26-130490.Report this figure13.2Current liabilities, Q1 FY2025, at 2025-03-31$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure7.1Current liabilities, Q2 FY2025, at 2025-06-30$7.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0000950170-25-106558.Report this figure3.5Current liabilities, Q3 FY2025, at 2025-09-30$3.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure3.3Current liabilities, FY2025, at 2025-12-31$3.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure3.3Current liabilities, Q1 FY2026, at 2026-03-31$3.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure4.5Current liabilities, Q2 FY2026, at 2026-06-30$4.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure
Total liabilities$m25.2Total liabilities, Q3 FY2023, at 2023-09-30$25.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-061278.Report this figure24.8Total liabilities, FY2023, at 2023-12-31$24.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0000950170-25-046144.Report this figure23.7Total liabilities, Q1 FY2024, at 2024-03-31$23.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-057072.Report this figure25.2Total liabilities, Q2 FY2024, at 2024-06-30$25.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-094124.Report this figure22.4Total liabilities, Q3 FY2024, at 2024-09-30$22.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figure22.4Total liabilities, FY2024, at 2024-12-31$22.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001193125-26-130490.Report this figure21.0Total liabilities, Q1 FY2025, at 2025-03-31$21.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure14.7Total liabilities, Q2 FY2025, at 2025-06-30$14.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0000950170-25-106558.Report this figure10.8Total liabilities, Q3 FY2025, at 2025-09-30$10.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure10.3Total liabilities, FY2025, at 2025-12-31$10.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure9.9Total liabilities, Q1 FY2026, at 2026-03-31$9.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure10.7Total liabilities, Q2 FY2026, at 2026-06-30$10.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure
Long-term debt$m8.4Long-term debt, Q3 FY2023, at 2023-09-30$8.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061278.Report this figure6.3Long-term debt, FY2023, at 2023-12-31$6.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-27, accession 0000950170-25-046144.Report this figure4.1Long-term debt, Q1 FY2024, at 2024-03-31$4.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-09, accession 0000950170-24-057072.Report this figure2.0Long-term debt, Q2 FY2024, at 2024-06-30$2.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094124.Report this figure0.0Long-term debt, Q3 FY2024, at 2024-09-30$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figure0.0Long-term debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-27, accession 0000950170-25-046144.Report this figure4.2Long-term debt, Q1 FY2025, at 2025-03-31$4.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figurenot reportednot reportednot reportednot reportednot reported
Current portion of debt$m2.1Current portion of debt, Q3 FY2023, at 2023-09-30$2.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061278.Report this figure4.3Current portion of debt, FY2023, at 2023-12-31$4.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-27, accession 0000950170-25-046144.Report this figure6.5Current portion of debt, Q1 FY2024, at 2024-03-31$6.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-057072.Report this figure8.6Current portion of debt, Q2 FY2024, at 2024-06-30$8.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094124.Report this figure8.5Current portion of debt, Q3 FY2024, at 2024-09-30$8.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figure6.4Current portion of debt, FY2024, at 2024-12-31$6.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-30, accession 0001193125-26-130490.Report this figure4.2Current portion of debt, Q1 FY2025, at 2025-03-31$4.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure0.0Current portion of debt, Q2 FY2025, at 2025-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-11, accession 0000950170-25-106558.Report this figure0.0Current portion of debt, Q3 FY2025, at 2025-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-30, accession 0001193125-26-130490.Report this figurenot reportednot reported
Shareholders' equity$m(1.2)Shareholders' equity, Q3 FY2023, at 2023-09-30−$1.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figure26.8Shareholders' equity, FY2023, at 2023-12-31$26.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001193125-26-130490.Report this figure20.6Shareholders' equity, Q1 FY2024, at 2024-03-31$20.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure16.9Shareholders' equity, Q2 FY2024, at 2024-06-30$16.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure11.5Shareholders' equity, Q3 FY2024, at 2024-09-30$11.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure19.1Shareholders' equity, FY2024, at 2024-12-31$19.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure11.1Shareholders' equity, Q1 FY2025, at 2025-03-31$11.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure9.8Shareholders' equity, Q2 FY2025, at 2025-06-30$9.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure6.3Shareholders' equity, Q3 FY2025, at 2025-09-30$6.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure6.7Shareholders' equity, FY2025, at 2025-12-31$6.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure0.8Shareholders' equity, Q1 FY2026, at 2026-03-31$822.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure(1.1)Shareholders' equity, Q2 FY2026, at 2026-06-30−$1.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure

Cash flow

Operating cash flow−$2.8m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Tempest Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(6.5)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125499. Derived: 9-month figure less the 6-month figure.Report this figure(6.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0000950170-25-046144. Derived: 12-month figure less the 9-month figure.Report this figure(7.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure(5.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0000950170-25-106558. Derived: 6-month figure less the 3-month figure.Report this figure(10.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$10.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-265946. Derived: 9-month figure less the 6-month figure.Report this figure(10.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$10.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001193125-26-130490. Derived: 12-month figure less the 9-month figure.Report this figure(8.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure(8.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$8.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349381. Derived: 6-month figure less the 3-month figure.Report this figure(6.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-265946. Derived: 9-month figure less the 6-month figure.Report this figure(3.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001193125-26-130490. Derived: 12-month figure less the 9-month figure.Report this figure(7.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure(2.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349381. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125499. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-27, accession 0000950170-25-046144. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$168.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure0.2Capital expenditure, Q2 FY2024, three months to 2024-06-30$249.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0000950170-25-106558. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$15.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-265946. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001193125-26-130490. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349381. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-265946. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001193125-26-130490. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349381. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)15.22m, Q2 FY2026
Tempest Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares13.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3013,635,927 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061278.Report this figure13.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3113,763,173 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-057072.Report this figure14.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3014,102,211 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-094124.Report this figure14.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3014,121,805 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125499.Report this figure1.7Diluted shares (weighted), Q1 FY2024, three months to 2024-03-311,710,323 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0000950170-25-070441.Report this figure1.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-301,734,335 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0000950170-25-106558.Report this figure2.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,985,133 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure3.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-313,437,671 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure3.8Diluted shares (weighted), Q2 FY2025, three months to 2025-06-303,802,956 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure4.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-304,440,111 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-265946.Report this figure10.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3110,931,593 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure15.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3015,223,972 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349381.Report this figure

Shares outstanding: 14.81mShares outstanding, period not labelled, at 2026-05-0814,806,997 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-224289.Report this figure at May 8, 2026, from the cover of the 10-Q filed May 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.